CSL LIMITED - Announcements

Market Cap $133.2B Add to my watchlist

Healthcare Biotechnology

Montu is a fully licensed medical cannabis company with a clear focus on the Australian... Montu is a fully licensed medical cannabis company with a clear focus on the Australian and New Zealand market. While the company offers its own medicinal-grade cannabis and cannabis-based medicines under the Circle brand, Montu's primary focus is making it easier for patients to access these crucial treatments.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) is stepping up its trial activities in Australia’s nearest Asian neighbour, Indonesia. Recce’s flagship anti-infective, R327, can be applied as a gel – and this gel-based version of the drug has been of specific interest...

Announcements

Filter Results

All Price Sensitive Only

CSL	CSL Vifor Market Briefing	PRICE SENSITIVE	17/10/22	2.81MB	Share
CSL	Notification of cessation of securities - CSL		14/10/22	21.44KB	Share
CSL	CSL 2022 AGM Results		12/10/22	167.48KB	Share
CSL	CSL 2022 AGM Chair and CEO Speech and Presentation		12/10/22	5.06MB	Share
CSL	Change of Director's Interest Notice		27/09/22	203.66KB	Share
CSL	Notification of cessation of securities - CSL		16/09/22	21.43KB	Share
CSL	Notification regarding unquoted securities - CSL		09/09/22	24.94KB	Share
CSL	Application for quotation of securities - CSL		09/09/22	26.91KB	Share
CSL	Update - Dividend/Distribution - CSL		09/09/22	25.35KB	Share
CSL	Notification regarding unquoted securities - CSL		02/09/22	25.4KB	Share
CSL	Change of Director's Interest Notice		02/09/22	233.17KB	Share
CSL	Change of Director's Interest Notice		02/09/22	298.06KB	Share
CSL	Notification of cessation of securities - CSL		02/09/22	21.43KB	Share
CSL	Notification regarding unquoted securities - CSL		02/09/22	24.5KB	Share
CSL	Application for quotation of securities - CSL		02/09/22	25.78KB	Share
CSL	Change of Director's Interest Notice		02/09/22	290.04KB	Share
CSL	CSL Annual Report 2022		02/09/22	5.75MB	Share
CSL	CSL Appendix 4G		02/09/22	269.23KB	Share
CSL	CSL Notice of Meeting and Shareholder Pack 2022		02/09/22	1.67MB	Share
CSL	Change of Director's Interest Notice (x8)		31/08/22	382.16KB	Share
CSL	Notification regarding unquoted securities - CSL		31/08/22	27.85KB	Share
CSL	Change of Director's Interest Notice		26/08/22	414.76KB	Share
CSL	Notification regarding unquoted securities - CSL		26/08/22	26.15KB	Share
CSL	Update - Dividend/Distribution - CSL		18/08/22	25.2KB	Share
CSL	CSL Results Presentation	PRICE SENSITIVE	17/08/22	2.06MB	Share
CSL	Dividend/Distribution - CSL		17/08/22	24.94KB	Share
CSL	CSL Results Announcement	PRICE SENSITIVE	17/08/22	185.98KB	Share
CSL	CSL Statutory Accounts for the Full Year Ended 30 June 202	PRICE SENSITIVE	17/08/22	3.13MB	Share
CSL	Notice of Investor/Analyst Briefing 2022 Full Year Result		16/08/22	93.19KB	Share
CSL	Notification of cessation of securities - CSL		10/08/22	21.43KB	Share
CSL	Completion of Vifor Pharma Acquisition		10/08/22	89.25KB	Share
CSL	Finalisation of Vifor Pharma Acquisition	PRICE SENSITIVE	02/08/22	111.59KB	Share
CSL	Becoming a substantial holder		22/07/22	492.71KB	Share
CSL	Notification of cessation of securities - CSL		05/07/22	21.43KB	Share
CSL	Notification of cessation of securities - CSL		09/06/22	21.43KB	Share
CSL	Vifor update ASX Announcement for lodgement	PRICE SENSITIVE	12/05/22	135.46KB	Share
CSL	Notification of cessation of securities - CSL		09/05/22	21.43KB	Share
CSL	Macquarie Presentation 2022		03/05/22	1.83MB	Share
CSL	CSL successfully issues bonds in US debt markets	PRICE SENSITIVE	21/04/22	130KB	Share
CSL	Notification of cessation of securities - CSL		08/04/22	21.43KB	Share
CSL	Update - Dividend/Distribution - CSL		14/03/22	25.28KB	Share
CSL	Notification of cessation of securities - CSL		08/03/22	21.43KB	Share
CSL	Notification regarding unquoted securities - CSL		07/03/22	24.93KB	Share
CSL	Notification regarding unquoted securities - CSL		04/03/22	25.02KB	Share
CSL	Update on Acquisition of Vifor Pharma	PRICE SENSITIVE	03/03/22	193.36KB	Share
CSL	Change of Director's Interest Notice		24/02/22	412.22KB	Share
CSL	Notification regarding unquoted securities - CSL		24/02/22	26.15KB	Share
CSL	Change of Director's Interest Notice		18/02/22	314.69KB	Share
CSL	Dividend/Distribution - CSL		16/02/22	24.78KB	Share
CSL	Half Year Results Investor Presentation	PRICE SENSITIVE	16/02/22	2.52MB	Share
CSL	Half Year Results Announcement	PRICE SENSITIVE	16/02/22	466.52KB	Share
CSL	Statutory Accounts for Half Year Ended 31 December 2021	PRICE SENSITIVE	16/02/22	532.26KB	Share
CSL	Application for quotation of securities - CSL		14/02/22	24.43KB	Share
CSL	CSL completes A$750 million Share Purchase Plan	PRICE SENSITIVE	14/02/22	143.3KB	Share
CSL	Notification of cessation of securities - CSL		08/02/22	21.43KB	Share
CSL	Notification of cessation of securities - CSL		17/01/22	21.43KB	Share
CSL	Notification regarding unquoted securities - CSL		07/01/22	24.46KB	Share
CSL	Change of Director's Interest Notice		29/12/21	192.15KB	Share
CSL	Proposal to Appoint Deloitte as External Auditor		22/12/21	81.64KB	Share
CSL	Share Purchase Plan		21/12/21	1.51MB	Share
CSL	Notice under section 708A(5)(e) of the Corporations Act		21/12/21	108.5KB	Share
CSL	Application for quotation of securities - CSL		20/12/21	23.57KB	Share
CSL	Successful Completion of A$6.3B Institutional Placement	PRICE SENSITIVE	16/12/21	180.03KB	Share
CSL	Proposed issue of securities - CSL		14/12/21	36.17KB	Share
CSL	Investor Presentation CSL Swiss Tender Acquisition of Vifor	PRICE SENSITIVE	14/12/21	2.92MB	Share
CSL	SWISS TENDER OFFER TO ACQUIRE 100% OF VIFOR PHARMA LTD	PRICE SENSITIVE	14/12/21	595.93KB	Share
CSL	Trading Halt	PRICE SENSITIVE	14/12/21	537.08KB	Share
CSL	Response to media speculation		13/12/21	111.26KB	Share
CSL	Notification of cessation of securities - CSL		06/12/21	21.43KB	Share
CSL	Response to Speculation		03/12/21	112.17KB	Share
CSL	Ceasing to be a substantial holder		22/11/21	627.36KB	Share
CSL	Change of Director's Interest Notice		18/11/21	201.35KB	Share
CSL	Notification of cessation of securities - CSL		12/11/21	21.51KB	Share
CSL	Ceasing to be a substantial holder		11/11/21	30.91KB	Share
CSL	Change of Director's Interest Notice		10/11/21	202.85KB	Share
CSL	Change of Director's Interest Notice		04/11/21	274.85KB	Share
CSL	2021 Annual R&D Day		19/10/21	7.7MB	Share
CSL	Change of Director's Interest Notice		15/10/21	203.72KB	Share
CSL	Notification regarding unquoted securities - CSL		15/10/21	26.59KB	Share
CSL	Results of Meeting		12/10/21	242.46KB	Share
CSL	CSL 2021 Annual General Meeting Speeches		12/10/21	1.81MB	Share
CSL	CSL Notice of Research & Development Investor Briefing		11/10/21	70.73KB	Share
CSL	Notification of cessation of securities - CSL		07/10/21	21.5KB	Share
CSL	Change of Director's Interest Notice		06/10/21	211.1KB	Share
CSL	Change of Director's Interest Notice		05/10/21	224.74KB	Share
CSL	Notification regarding unquoted securities - CSL		05/10/21	26.1KB	Share
CSL	Application for quotation of securities - CSL		04/10/21	24.83KB	Share
CSL	Application for quotation of securities - CSL		17/09/21	24.84KB	Share
CSL	Application for quotation of securities - CSL		14/09/21	24.84KB	Share
CSL	Notification regarding unquoted securities - CSL		09/09/21	26.38KB	Share
CSL	Update - Dividend/Distribution - CSL		07/09/21	25.38KB	Share
CSL	Application for quotation of securities - CSL		07/09/21	27.11KB	Share
CSL	Change of Director's Interest Notice		03/09/21	216.73KB	Share
CSL	Change of Director's Interest Notice		03/09/21	293.28KB	Share
CSL	Notification of cessation of securities - CSL		03/09/21	21.5KB	Share
CSL	Application for quotation of securities - CSL		03/09/21	25.93KB	Share
CSL	Appendix 4G		03/09/21	267.11KB	Share
CSL	CSL Notice of Meeting and Shareholder Pack 2021		03/09/21	2MB	Share
CSL	CSL Annual Report		03/09/21	6.78MB	Share
CSL	Change of Director's Interest Notice		27/08/21	371.63KB	Share

CSL CSL Vifor Market Briefing
17/10/22	PRICE SENSITIVE	2.81MB	Share
CSL Notification of cessation of securities - CSL
14/10/22		21.44KB	Share
CSL CSL 2022 AGM Results
12/10/22		167.48KB	Share
CSL CSL 2022 AGM Chair and CEO Speech and Presentation
12/10/22		5.06MB	Share
CSL Change of Director's Interest Notice
27/09/22		203.66KB	Share
CSL Notification of cessation of securities - CSL
16/09/22		21.43KB	Share
CSL Notification regarding unquoted securities - CSL
09/09/22		24.94KB	Share
CSL Application for quotation of securities - CSL
09/09/22		26.91KB	Share
CSL Update - Dividend/Distribution - CSL
09/09/22		25.35KB	Share
CSL Notification regarding unquoted securities - CSL
02/09/22		25.4KB	Share
CSL Change of Director's Interest Notice
02/09/22		233.17KB	Share
CSL Change of Director's Interest Notice
02/09/22		298.06KB	Share
CSL Notification of cessation of securities - CSL
02/09/22		21.43KB	Share
CSL Notification regarding unquoted securities - CSL
02/09/22		24.5KB	Share
CSL Application for quotation of securities - CSL
02/09/22		25.78KB	Share
CSL Change of Director's Interest Notice
02/09/22		290.04KB	Share
CSL CSL Annual Report 2022
02/09/22		5.75MB	Share
CSL CSL Appendix 4G
02/09/22		269.23KB	Share
CSL CSL Notice of Meeting and Shareholder Pack 2022
02/09/22		1.67MB	Share
CSL Change of Director's Interest Notice (x8)
31/08/22		382.16KB	Share
CSL Notification regarding unquoted securities - CSL
31/08/22		27.85KB	Share
CSL Change of Director's Interest Notice
26/08/22		414.76KB	Share
CSL Notification regarding unquoted securities - CSL
26/08/22		26.15KB	Share
CSL Update - Dividend/Distribution - CSL
18/08/22		25.2KB	Share
CSL CSL Results Presentation
17/08/22	PRICE SENSITIVE	2.06MB	Share
CSL Dividend/Distribution - CSL
17/08/22		24.94KB	Share
CSL CSL Results Announcement
17/08/22	PRICE SENSITIVE	185.98KB	Share
CSL CSL Statutory Accounts for the Full Year Ended 30 June 202
17/08/22	PRICE SENSITIVE	3.13MB	Share
CSL Notice of Investor/Analyst Briefing 2022 Full Year Result
16/08/22		93.19KB	Share
CSL Notification of cessation of securities - CSL
10/08/22		21.43KB	Share
CSL Completion of Vifor Pharma Acquisition
10/08/22		89.25KB	Share
CSL Finalisation of Vifor Pharma Acquisition
02/08/22	PRICE SENSITIVE	111.59KB	Share
CSL Becoming a substantial holder
22/07/22		492.71KB	Share
CSL Notification of cessation of securities - CSL
05/07/22		21.43KB	Share
CSL Notification of cessation of securities - CSL
09/06/22		21.43KB	Share
CSL Vifor update ASX Announcement for lodgement
12/05/22	PRICE SENSITIVE	135.46KB	Share
CSL Notification of cessation of securities - CSL
09/05/22		21.43KB	Share
CSL Macquarie Presentation 2022
03/05/22		1.83MB	Share
CSL CSL successfully issues bonds in US debt markets
21/04/22	PRICE SENSITIVE	130KB	Share
CSL Notification of cessation of securities - CSL
08/04/22		21.43KB	Share
CSL Update - Dividend/Distribution - CSL
14/03/22		25.28KB	Share
CSL Notification of cessation of securities - CSL
08/03/22		21.43KB	Share
CSL Notification regarding unquoted securities - CSL
07/03/22		24.93KB	Share
CSL Notification regarding unquoted securities - CSL
04/03/22		25.02KB	Share
CSL Update on Acquisition of Vifor Pharma
03/03/22	PRICE SENSITIVE	193.36KB	Share
CSL Change of Director's Interest Notice
24/02/22		412.22KB	Share
CSL Notification regarding unquoted securities - CSL
24/02/22		26.15KB	Share
CSL Change of Director's Interest Notice
18/02/22		314.69KB	Share
CSL Dividend/Distribution - CSL
16/02/22		24.78KB	Share
CSL Half Year Results Investor Presentation
16/02/22	PRICE SENSITIVE	2.52MB	Share
CSL Half Year Results Announcement
16/02/22	PRICE SENSITIVE	466.52KB	Share
CSL Statutory Accounts for Half Year Ended 31 December 2021
16/02/22	PRICE SENSITIVE	532.26KB	Share
CSL Application for quotation of securities - CSL
14/02/22		24.43KB	Share
CSL CSL completes A$750 million Share Purchase Plan
14/02/22	PRICE SENSITIVE	143.3KB	Share
CSL Notification of cessation of securities - CSL
08/02/22		21.43KB	Share
CSL Notification of cessation of securities - CSL
17/01/22		21.43KB	Share
CSL Notification regarding unquoted securities - CSL
07/01/22		24.46KB	Share
CSL Change of Director's Interest Notice
29/12/21		192.15KB	Share
CSL Proposal to Appoint Deloitte as External Auditor
22/12/21		81.64KB	Share
CSL Share Purchase Plan
21/12/21		1.51MB	Share
CSL Notice under section 708A(5)(e) of the Corporations Act
21/12/21		108.5KB	Share
CSL Application for quotation of securities - CSL
20/12/21		23.57KB	Share
CSL Successful Completion of A$6.3B Institutional Placement
16/12/21	PRICE SENSITIVE	180.03KB	Share
CSL Proposed issue of securities - CSL
14/12/21		36.17KB	Share
CSL Investor Presentation CSL Swiss Tender Acquisition of Vifor
14/12/21	PRICE SENSITIVE	2.92MB	Share
CSL SWISS TENDER OFFER TO ACQUIRE 100% OF VIFOR PHARMA LTD
14/12/21	PRICE SENSITIVE	595.93KB	Share
CSL Trading Halt
14/12/21	PRICE SENSITIVE	537.08KB	Share
CSL Response to media speculation
13/12/21		111.26KB	Share
CSL Notification of cessation of securities - CSL
06/12/21		21.43KB	Share
CSL Response to Speculation
03/12/21		112.17KB	Share
CSL Ceasing to be a substantial holder
22/11/21		627.36KB	Share
CSL Change of Director's Interest Notice
18/11/21		201.35KB	Share
CSL Notification of cessation of securities - CSL
12/11/21		21.51KB	Share
CSL Ceasing to be a substantial holder
11/11/21		30.91KB	Share
CSL Change of Director's Interest Notice
10/11/21		202.85KB	Share
CSL Change of Director's Interest Notice
04/11/21		274.85KB	Share
CSL 2021 Annual R&D Day
19/10/21		7.7MB	Share
CSL Change of Director's Interest Notice
15/10/21		203.72KB	Share
CSL Notification regarding unquoted securities - CSL
15/10/21		26.59KB	Share
CSL Results of Meeting
12/10/21		242.46KB	Share
CSL CSL 2021 Annual General Meeting Speeches
12/10/21		1.81MB	Share
CSL CSL Notice of Research & Development Investor Briefing
11/10/21		70.73KB	Share
CSL Notification of cessation of securities - CSL
07/10/21		21.5KB	Share
CSL Change of Director's Interest Notice
06/10/21		211.1KB	Share
CSL Change of Director's Interest Notice
05/10/21		224.74KB	Share
CSL Notification regarding unquoted securities - CSL
05/10/21		26.1KB	Share
CSL Application for quotation of securities - CSL
04/10/21		24.83KB	Share
CSL Application for quotation of securities - CSL
17/09/21		24.84KB	Share
CSL Application for quotation of securities - CSL
14/09/21		24.84KB	Share
CSL Notification regarding unquoted securities - CSL
09/09/21		26.38KB	Share
CSL Update - Dividend/Distribution - CSL
07/09/21		25.38KB	Share
CSL Application for quotation of securities - CSL
07/09/21		27.11KB	Share
CSL Change of Director's Interest Notice
03/09/21		216.73KB	Share
CSL Change of Director's Interest Notice
03/09/21		293.28KB	Share
CSL Notification of cessation of securities - CSL
03/09/21		21.5KB	Share
CSL Application for quotation of securities - CSL
03/09/21		25.93KB	Share
CSL Appendix 4G
03/09/21		267.11KB	Share
CSL CSL Notice of Meeting and Shareholder Pack 2021
03/09/21		2MB	Share
CSL CSL Annual Report
03/09/21		6.78MB	Share
CSL Change of Director's Interest Notice
27/08/21		371.63KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last $275.80		Change 0.410(0.15%)		Mkt cap ! $133.2B

Open	High	Low	Value	Volume
$276.00	$277.50	$274.44	$131.0M	472.2K

Buyers (Bids)

No.	Vol.	Price($)
1	83	$275.78

Sellers (Offers)

Price($)	Vol.	No.
$275.93	109	1

View Market Depth

No.	Vol.	Price($)
1	50	275.600
1	47	275.450
1	2	275.370
1	100	275.300
2	128	275.000

Price($)	Vol.	No.
276.000	160	1
276.920	130	1
277.000	30	2
277.500	108	1
277.870	86	1

Last trade - 16.10pm 03/05/2024 (20 minute delay)


Last $276.25		Change 0.410 ( 0.14 %)
Open	High	Low	Volume
$276.01	$277.50	$274.48	149758
Last updated 15.59pm 03/05/2024 ?

CSL (ASX) Chart

CSL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories